医学临床研究
  2025年4月6日 星期日           首 页    |    期刊简介    |    编委会    |    投稿指南    |    期刊订阅    |    广告合作    |    留言板    |    联系我们    |    English
医学临床研究  2020, Vol. 37 Issue (11): 1691-1693    DOI: 10.3969/j.issn.1671-7171.2020.11.028
  论著 本期目录 | 过刊浏览 | 高级检索 |
失代偿期乙型肝炎肝硬化患者血清PA、MMP-2、CYFRA21-1水平及意义
夏笑笑1, 史冬涛2
1.海安人民医院 江苏 海安 226600;
2.苏州大学附属第一医院,江苏 苏州 215008
Levels and Significance of Serum PA, MMP-2, CYFRA21-1 in Patients with Decompensated Hepatitis B Cirrhosis
XIA Xiao-xiao, SHI Dong-tao
Hai'an Peoples Hospital,Jiangsu Hai'an 226600
全文: PDF (0 KB)   HTML (1 KB) 
输出: BibTeX | EndNote (RIS)      
摘要 目的】探讨失代偿期乙型肝炎(乙肝)肝硬化患者血清前白蛋白(PA)、基质金属蛋白酶-2(MMP-2)、细胞角蛋白19片段(CYFRA21-1)水平及意义。【方法】慢性乙肝患者68例(慢性组)、乙肝肝硬化代偿期患者50例(代偿组)、乙型肝炎肝硬化失代偿期患者42例(失代偿组),同时选取健康志愿者60例作为对照组,检测比较其血清PA、MMP-2、CYFRA21-1水平。【结果】血清PA水平由低至高依次为失代偿组、代偿组、慢性组和对照组,且各组之间相比较差异均有显著性(P<0.05),而MMP-2和CYFRA21-1由高至低依次为失代偿组、代偿组、慢性组和对照组,且各组之间相比较差异均有显著性(P<0.05)。失代偿组死亡患者血清PA为(37.22±9.94)mg/L,明显低于存活患者(P<0.05),而MMP-2和CYFRA21-1为(1.50±0.27)ng/L和(1.56±0.24)ng/mL,明显高于存活患者(P<0.05);血清PA、MMP-2、CYFRA21-1水平预测乙型肝炎肝硬化失代偿期患者死亡的ROC曲线下面积分别为0.911、0.736和0.686(均P<0.05)。【结论】失代偿期乙肝肝硬化患者血清PA明显降低,而MMP-2和CYFRA21-1明显升高,三者在预测预后方面有一定应用价值。
服务
把本文推荐给朋友
加入我的书架
加入引用管理器
E-mail Alert
RSS
作者相关文章
夏笑笑
史冬涛
关键词 肝炎, 乙型/并发症肝硬化/病因学基质金属蛋白酶2/血液前白蛋白/血液角蛋白类/血液    
Abstract:【Objective】To investigate the levels and significance of serum prealbumin (PA), matrix metalloproteinase-2 (MMP-2) and cytokeratin 19 fragment (CYFRA21-1) in patients with decompensated hepatitis B(HB) cirrhosis. 【Methods】Sixty-eight patients with chronic HB (chronic group), 50 patients with compensatory HB cirrhosis (compensatory group) and 42 patients with decompensated HB cirrhosis (decompensated group) were selected,and 60 healthy volunteers were selected as control group;serum PA, MMP-2 and CYFRA21-1 level were detected. 【Results】The levels of serum PA from low to high were the decompensated group, the bcompensatory group, the chronic group and the control group, and the differences were significant (P<0.05). MMP-2 and CYFRA21-1 from high to low were the decompensated group, the compensatory group, the chronic group and the control group, and there were significant differences among each group (P<0.05). In the decompensated group, serum PA was (37.22±9.94) mg/L, which was significantly lower than that of survival patients (P<0.05), while MMP-2 and CYFRA21-1 were (1.50±0.27) ng/L and (1.56±0.24) ng/mL, which were significantly higher than those of survival patients (P<0.05). The area under ROC curve for predicting death of patients with decompensated hepatitis B cirrhosis by serum PA, MMP-2 and CYFRA21-1 was 0.911, 0.736 and 0.686, respectively( All P<0.05). 【Conclusion】Serum PA is significantly decreased in patients with decompensated hepatitis B cirrhosis, while MMP-2 and CYFRA21-1 are significantly increased in patients with decompensated hepatitis B cirrhosis.The three methods have certain application value in predicting prognosis.
Key wordsHepatitis B/CO    Liver Cirrhosis/ET    Matrix Metalloproteinase 2/BL    Prealbumin/BL    Keratins/BL
收稿日期: 2019-08-12     
PACS:  R657.31  
引用本文:   
夏笑笑, 史冬涛. 失代偿期乙型肝炎肝硬化患者血清PA、MMP-2、CYFRA21-1水平及意义[J]. 医学临床研究, 2020, 37(11): 1691-1693.
XIA Xiao-xiao, SHI Dong-tao. Levels and Significance of Serum PA, MMP-2, CYFRA21-1 in Patients with Decompensated Hepatitis B Cirrhosis. JOURNAL OF CLINICAL RESEARCH, 2020, 37(11): 1691-1693.
链接本文:  
http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2020.11.028     或     http://journal07.magtech.org.cn/yxlcyj/CN/Y2020/V37/I11/1691
版权所有 © 2013 医学临床研究杂志社  湘ICP备13012052号-1
办公地址:湖南省长沙市芙蓉区新军路43号煤炭大院主办公楼6楼621、623、632、636室 邮编:410011 电话(传真):0731-84824007 E-mail:jcr_cs.hn@vip.163.com
技术支持:北京玛格泰克科技发展有限公司 技术支持:support@magtech.com.cn